Effectiveness and safety of thiotepa as conditioning treatment prior to stem cell transplant in patients with central nervous system lymphoma.

about

Effectiveness and safety of thiotepa as conditioning treatment prior to stem cell transplant in patients with central nervous system lymphoma.

Item

http://www.wikidata.org/entity/Q38184642

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Effectiveness and safety of th ...... ntral nervous system lymphoma.

@en

type

Item

label

Effectiveness and safety of th ...... ntral nervous system lymphoma.

@en

prefLabel

Effectiveness and safety of th ...... ntral nervous system lymphoma.

@en

P1476

Effectiveness and safety of th ...... entral nervous system lymphoma

@en

P2093

Alan T Tinmouth

http://www.w3.org/2001/XMLSchema#string

Chris Bredeson

http://www.w3.org/2001/XMLSchema#string

Douglas Stewart

http://www.w3.org/2001/XMLSchema#string

Joseph O'Neill

http://www.w3.org/2001/XMLSchema#string

Madzouka B Kokolo

http://www.w3.org/2001/XMLSchema#string

P2860

Inappropriate antidiuretic hormone secretion after high-dose thiotepa

Central nervous system disease in hematologic malignancies: historical perspective and practical applications.

Non-enhancing relapse of a primary CNS lymphoma with multiple diffusion-restricted lesions.

Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide (TBC) conditioning in patients with CNS involvement by non-Hodgkin lymphoma.

Intensive chemotherapy with thiotepa, busulfan and cyclophosphamide and hematopoietic stem cell rescue in relapsed or refractory primary central nervous system lymphoma and intraocular lymphoma: a retrospective study of 79 cases.

Chemotherapy for primary central nervous system lymphoma.

High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma.

Favorable outcome of primary CNS anaplastic large cell lymphoma in an immunocompetent patient.

Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire.

A phase II evaluation of thiotepa in pediatric central nervous system malignancies.

P304

2712-2720

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.3109/10428194.2014.889825

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dean A Fergusson

Jason Tay

P577

2014-03-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24491026

http://www.w3.org/2001/XMLSchema#string